Exercise in End-Stage Renal Disease

被引:38
|
作者
Segura-Orti, Eva [1 ]
Johansen, Kirsten L. [2 ,3 ,4 ]
机构
[1] Univ CEU Cardenal Herrera, Dept Phys Therapy, Valencia, Spain
[2] Univ Calif San Francisco, Dept Med, San Francisco, CA USA
[3] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA
[4] San Francisco VA Med Ctr, Nephrol Sect, San Francisco, CA USA
关键词
QUALITY-OF-LIFE; MAINTENANCE HEMODIALYSIS-PATIENTS; WEIGHT-LOSS; PHYSICAL FUNCTION; DIALYSIS PATIENTS; AEROBIC CAPACITY; CONTROLLED-TRIAL; MUSCLE STRENGTH; KIDNEY-DISEASE; HEALTH-STATUS;
D O I
10.1111/j.1525-139X.2010.00766.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
This article will outline the clinical reasoning for exercise counseling in end-stage renal disease (ESRD) patients and give healthcare providers detailed information on the different programs that can be implemented in this population according to patients' specific needs. End-stage renal disease patients often have other health problems that can be improved by participation in regular exercise programs. Research accumulated during the last 30 years on exercise for the ESRD population supports its numerous beneficial effects including those on cardiovascular capacity, sarcopenia, and health-related quality of life. We describe the different types of exercise, aerobic and resistance programs (including their frequency, intensity and progression) that are recommended for the ESRD population, as well as the potential goals of each program. Groups with special needs among the ESRD population are considered, as well as safety, potential adverse events, and adherence to exercise programs. Finally, recommendations for future researches are highlighted.
引用
收藏
页码:422 / 430
页数:9
相关论文
共 50 条
  • [41] Hyperphosphatemia in end-stage renal disease
    Indridason, OS
    Quarles, LD
    [J]. ADVANCES IN RENAL REPLACEMENT THERAPY, 2002, 9 (03): : 184 - 192
  • [42] End-stage renal disease and thrombophilia
    Bauer, Alexander
    Limperger, Verena
    Nowak-Goettl, Ulrike
    [J]. HAMOSTASEOLOGIE, 2016, 36 (02): : 103 - 107
  • [43] Erythropoietin for end-stage renal disease
    Adamson, JW
    Eschbach, JW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (09): : 625 - 627
  • [44] Preventing end-stage renal disease
    Mogensen, CE
    [J]. DIABETIC MEDICINE, 1998, 15 (12) : S51 - S56
  • [45] Depression in End-Stage Renal Disease
    Fallon, Margaret
    [J]. JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES, 2011, 49 (08) : 30 - 34
  • [46] Thrombosis in end-stage renal disease
    Tveit, DP
    Abbott, KC
    [J]. SEMINARS IN DIALYSIS, 2004, 17 (01) : 71 - 71
  • [47] HYPERTENSION IN END-STAGE RENAL DISEASE
    VERTES, V
    CANGIANO, J
    BERMAN, L
    [J]. CIRCULATION, 1969, 40 (4S3) : I208 - &
  • [48] Dealing with end-stage renal disease
    SosaGuerrero, S
    Gomez, NJ
    [J]. AMERICAN JOURNAL OF NURSING, 1997, 97 (10) : 44 - 50
  • [49] Thyroid disease in end-stage renal disease
    Rhee, Connie M.
    [J]. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2019, 28 (06): : 621 - 630
  • [50] End-stage renal disease in Fabry disease
    Granata, A.
    Romeo, G.
    Gulisano, S.
    Leonardi, G.
    Romano, R.
    Manca, E.
    Fiumara, A.
    Sicurezza, E.
    [J]. CLINICAL THERAPEUTICS, 2007, 29 : S20 - S20